Treatment Patterns of Thiopurines in a Danish Population Diagnosed with Inflammatory Bowel Disease: A Drug Utilization Study

被引：0
|
作者：
Kristensen, Marie S. [1 ]
Kjaerulff, Thora M. [1 ]
Thygesen, Lau C. [1 ]
Knudsen, Nikoline N. [1 ]
Green, Anders [2 ]
Andersen, Vibeke [3 ]
Ersboll, Annette K. [1 ]
机构：
[1] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark
[2] Inst Appl Econ & Hlth Res, Copenhagen, Denmark
[3] Univ Southern Denmark, Inst Mol Med, Odense, Denmark
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2016年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
1090
引用
收藏
页码：633 / 634
页数：2
相关论文
共 50 条
  • [31] Real-world drug utilization in patients with inflammatory bowel disease: A population-based study in Taiwan
    Yang, Er-Hsiang
    Lien, Pei-Wen
    Cheng, Ching-Lan
    Pao, Peng-Wen
    Wei, Shu-Chen
    Chuang, Chiao-Hsiung
    Shieh, Ming-Jium
    Khalid, Javaria Mona
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 480 - 480
  • [32] Risk of dementia in patients with inflammatory bowel disease: a Danish population-based study
    Sand, Jakob Ronnow
    Troelsen, Frederikke Schonfeldt
    Horvath-Puho, Erzsebet
    Henderson, Victor W.
    Sorensen, Henrik Toft
    Erichsen, Rune
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (05) : 831 - 843
  • [33] On Therapeutic Drug Monitoring of Thiopurines in Inflammatory Bowel Disease; Pharmacology, Pharmacogenomics, Drug Intolerance and Clinical Relevance
    Van Asseldonk, Dirk P.
    de Boer, Nanne K. H.
    Peters, Godefridus J.
    Veldkamp, Agnes I.
    Mulder, Chris J.
    Van Bodegraven, Ad A.
    CURRENT DRUG METABOLISM, 2009, 10 (09) : 981 - 997
  • [34] Pharmacology and Optimization of Thiopurines and Methotrexate in Inflammatory Bowel Disease
    Mehmet Coskun
    Casper Steenholdt
    Nanne K. de Boer
    Ole Haagen Nielsen
    Clinical Pharmacokinetics, 2016, 55 : 257 - 274
  • [35] Drug Utilization Patterns of Tumor Necrosis Factor Inhibitor Agents in a Population with Inflammatory Bowel Disease from 2009 to 2014 in Denmark
    Kjaerulff, Thora M.
    Christensen, Marie S.
    Ersboll, Annette K.
    Knudsen, Nikoline N.
    Green, Anders
    Andersen, Vibeke
    Thygesen, Lau C.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 634 - 635
  • [36] Use of thiopurines in inflammatory bowel disease: Safety issues
    Anastasia Konidari
    Wael El Matary
    World Journal of Gastrointestinal Pharmacology and Therapeutics, 2014, (02) : 63 - 76
  • [37] Thiopurines in Inflammatory Bowel Disease: New Findings and Perspectives
    de Boer, Nanne K. H.
    Peyrin-Biroulet, Laurent
    Jharap, Bindia
    Sanderson, Jeremy D.
    Meijer, Berrie
    Atreya, Imke
    Barclay, Murray L.
    Colombel, Jean-Frederic
    Lopez, Anthony
    Beaugerie, Laurent
    Marinaki, Anthony M.
    van Bodegraven, Adriaan A.
    Neurath, Markus F.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 (05): : 610 - 620
  • [38] Pharmacology and Optimization of Thiopurines and Methotrexate in Inflammatory Bowel Disease
    Coskun, Mehmet
    Steenholdt, Casper
    de Boer, Nanne K.
    Nielsen, Ole Haagen
    CLINICAL PHARMACOKINETICS, 2016, 55 (03) : 257 - 274
  • [39] Update on the Use of Thiopurines and Methotrexate in Inflammatory Bowel Disease
    Johnson C.M.
    Dassopoulos T.
    Current Gastroenterology Reports, 2018, 20 (11)
  • [40] Enduring Value of Thiopurines for Inflammatory Bowel Disease Therapy
    Korelitz, Burton I.
    DIGESTIVE DISEASES AND SCIENCES, 2017, 62 (02) : 292 - 293
12345